Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Sandra A Radema"'
Autor:
Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Geert‐Jan M. Creemers, Frans L. G. Erdkamp, Felix E. deJongh, Peter A. M. Kint, Boelo J. Poppema, Sandra A. Radema, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman, Anne M. May
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Abstract Background Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown. Methods This is a
Externí odkaz:
https://doaj.org/article/434f0b15ebe24d0abcf39821804c932c
Autor:
Erik J. vanHelden, Lindsay Angus, C. Willemien Menke‐van der Houven van Oordt, Daniëlle A. M. Heideman, Eline Boon, Suzanne C. vanEs, Sandra A. Radema, Carla M. L. vanHerpen, Derk Jan A. deGroot, Elisabeth G. E. deVries, Maurice P. H. M. Jansen, Stefan Sleijfer, Henk M. W. Verheul
Publikováno v:
Molecular Oncology, Vol 13, Iss 11, Pp 2361-2374 (2019)
In metastatic colorectal cancer, RAS and BRAF mutations cause resistance to anti‐EGFR therapies, such as cetuximab. Heterogeneity in RAS and BRAF mutations might explain nonresponse in a subset of patients receiving cetuximab. Analyzing mutations i
Externí odkaz:
https://doaj.org/article/55eb68fb8dbf4d9b8e6e70877c64b61e
Autor:
Koen P. Rovers, Checca Bakkers, Geert A. A. M. Simkens, Jacobus W. A. Burger, Simon W. Nienhuijs, Geert-Jan M. Creemers, Anna M. J. Thijs, Alexandra R. M. Brandt-Kerkhof, Eva V. E. Madsen, Ninos Ayez, Nadine L. de Boer, Esther van Meerten, Jurriaan B. Tuynman, Miranda Kusters, Nina R. Sluiter, Henk M. W. Verheul, Hans J. van der Vliet, Marinus J. Wiezer, Djamila Boerma, Emma C. E. Wassenaar, Maartje Los, Cornelis B. Hunting, Arend G. J. Aalbers, Niels F. M. Kok, Koert F. D. Kuhlmann, Henk Boot, Myriam Chalabi, Schelto Kruijff, Lukas B. Been, Robert J. van Ginkel, Derk Jan A. de Groot, Rudolf S. N. Fehrmann, Johannes H. W. de Wilt, Andreas J. A. Bremers, Philip R. de Reuver, Sandra A. Radema, Karin H. Herbschleb, Wilhelmina M. U. van Grevenstein, Arjen J. Witkamp, Miriam Koopman, Nadia Haj Mohammad, Eino B. van Duyn, Walter J. B. Mastboom, Leonie J. M. Mekenkamp, Joost Nederend, Max J. Lahaye, Petur Snaebjornsson, Cornelis Verhoef, Hanneke W. M. van Laarhoven, Aeilko H. Zwinderman, Jeanette M. Bouma, Onno Kranenburg, Iris van ‘t Erve, Remond J. A. Fijneman, Marcel G. W. Dijkgraaf, Patrick H. J. Hemmer, Cornelis J. A. Punt, Pieter J. Tanis, Ignace H. J. T. de Hingh, Dutch Peritoneal Oncology Group (DPOG), Dutch Colorectal Cancer Group (DCCG)
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background Upfront cytoreductive surgery with HIPEC (CRS-HIPEC) is the standard treatment for isolated resectable colorectal peritoneal metastases (PM) in the Netherlands. This study investigates whether addition of perioperative systemic th
Externí odkaz:
https://doaj.org/article/0eae7e00e09f44039f07a47639a0e680
Autor:
Sandra A. S. van den Heuvel, Selina E. I. van der Wal, Lotte A. Smedes, Sandra A. Radema, Nens van Alfen, Kris C. P. Vissers, Monique A. H. Steegers
Publikováno v:
Pain Research and Management, Vol 2017 (2017)
Background. Treatment of intractable pain due to chemotherapy induced peripheral neuropathy (CIPN) is a challenge. Intravenous (iv) lidocaine has shown to be a treatment option for neuropathic pain of different etiologies. Methods. Lidocaine (1.5 mg/
Externí odkaz:
https://doaj.org/article/bc53c8ff2457497e93ee2bd029913c50
Autor:
Jorine 't Lam-Boer, Cornelis Verhoef, Marlies G Verstegen, Jennifer M J Schreinemakers, Sandra A Radema, Johannes H. W. de Wilt, Jan-Marie de Gooyer, Rob H.A. Verhoeven
Publikováno v:
Digestive Surgery, 37, 292-301
Digestive Surgery, 37, 4, pp. 292-301
Digestive Surgery, 37(4), 292-301. Karger
Digestive Surgery, 37, 4, pp. 292-301
Digestive Surgery, 37(4), 292-301. Karger
Introduction: Neoadjuvant chemotherapy (CT) for locally advanced colon cancer (LACC) could potentially lead to tumor shrinkage, eradication of micrometastases, and prevention of tumor cell shedding during surgery. This retrospective study investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51a0ca014bbee94a477212ee43e480d
https://doi.org/10.1159/000503446
https://doi.org/10.1159/000503446
Autor:
Ignace H. J. T. de Hingh, Erwin van der Harst, Victor J. Verwaal, Edwin S. van der Zaag, Karlijn van Woensdregt, R.T.J. Kortekaas, Bas Inberg, Sebastiaan Festen, Petur Snaebjornsson, Karin K. van Diepen, Anna A. W. van Geloven, Alexandra Brandt, Roderick F. Schmitz, Pieter J. Tanis, Koen C.M.J. Peeters, Cornelis J. A. Punt, Eva V. E. Madsen, Sanne C. Veltkamp, Charlotte E. L. Klaver, Johanne Bloemen, P.A. Neijenhuis, Eino B. van Duyn, Thomas J.M. Kootstra, Henderik L van Westreenen, Johannes H. W. de Wilt, T.C. van Sprundel, Emma C. E. Wassenaar, M. Westerterp, Philip R. de Reuver, Jennifer Demelinne, Dirkje W. Sommeijer, Loes van den Nieuwenhof, Marinus J. Wiezer, H.C.J. van der Mijle, Pauline Evers, Rogier M P H Crolla, Annette A van Zweeden, Joost T. Heikens, Daniel A. Hess, Marcel G. W. Dijkgraaf, Jan Jansen, D. J. A. Sonneveld, Anthony W. H. van de Ven, Frank W.H. Kloppenberg, Mandy Zournas, Patrick H. J. Hemmer, Koen P. Rovers, J. W. T. Dekker, Daniel D Wisselink, Jacobus W. A. Burger, Huib A. Cense, Esther D. van den Ende, David D. E. Zimmerman, Wilhelmina M U van Grevenstein, Frank C. den Boer, Jarmila D. W. van der Bilt, Sandra A Radema, Vivian P. Bastiaenen, Djamila Boerma, Johannes Crezee, Maarten Vermaas, Hans F. J. Fabry, Maartje Los, Floris Ferenschild, Lotte Schoonderwoerd, Walter J.A. Brokelman, Jeroen Heemskerk, Pieter Poortman, Jurriaan B. Tuynman, Johannes A. Wegdam, Marc J. van Det, Linda Mol, Bert van Ramshorst, Arend G. J. Aalbers, Marjolein Diepeveen, Gijsbert D. Musters, Arjen J. Witkamp, Daan ten Bokkel Huinink, Niels F. M. Kok, Simon W. Nienhuijs, Willem A. Bemelman, Geert-Jan Creemers, Jolien Pon, Caroline S. Andeweg, Sebastiaan W. Polle, Esther C. J. Consten, Nina R. Sluiter, Fennie Wit, A.J.A. Bremers
Publikováno v:
Lancet Gastroenterology & Hepatology, 4, 761-770
Lancet Gastroenterology & Hepatology, 4, 10, pp. 761-770
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet. Gastroenterology & hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
The Lancet Gastroenterology and Hepatology, 4(10), 761-770. Elsevier Ltd
The Lancet Gastroenterology and Hepatology, 4(10), 761. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4(10), 761-770. Elsevier Ltd.
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J, COLOPEC collaborators group & Jilbert Verwaal, V 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Lancet gastroenterology & hepatology, 4(10), 761-770. HANLEY & BELFUS-ELSEVIER INC
lancet. Gastroenterology & hepatology, 4(10), 761-770. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4, 10, pp. 761-770
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet. Gastroenterology & hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J & COLOPEC collaborators group 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
The Lancet Gastroenterology and Hepatology, 4(10), 761-770. Elsevier Ltd
The Lancet Gastroenterology and Hepatology, 4(10), 761. Elsevier Limited
Lancet Gastroenterology & Hepatology, 4(10), 761-770. Elsevier Ltd.
Klaver, C E L, Wisselink, D D, Punt, C J A, Snaebjornsson, P, Crezee, J, Aalbers, A G J, Brandt, A, Bremers, A J A, Burger, J W A, Fabry, H F J, Ferenschild, F, Festen, S, van Grevenstein, W M U, Hemmer, P H J, de Hingh, I H J T, Kok, N F M, Musters, G D, Schoonderwoerd, L, Tuynman, J B, van de Ven, A W H, van Westreenen, H L, Wiezer, M J, Zimmerman, D D E, van Zweeden, A A, Dijkgraaf, M G W, Tanis, P J, COLOPEC collaborators group & Jilbert Verwaal, V 2019, ' Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 10, pp. 761-770 . https://doi.org/10.1016/S2468-1253(19)30239-0
Lancet gastroenterology & hepatology, 4(10), 761-770. HANLEY & BELFUS-ELSEVIER INC
lancet. Gastroenterology & hepatology, 4(10), 761-770. Elsevier Limited
BACKGROUND: Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon cancer are at risk of developing peritoneal metastases, often without curative treatment options. We aimed to determine the efficacy of adjuvant hyperthermi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655a1b85752b72c7a1b1efab9318639a
https://doi.org/10.1016/s2468-1253(19)30239-0
https://doi.org/10.1016/s2468-1253(19)30239-0
Autor:
Jonne Doorduin, Sandra A Radema, Selina E I van der Wal, Kris Vissers, Monique A H Steegers, Nens van Alfen, Ewald M. Bronkhorst, Sandra A S van den Heuvel
Publikováno v:
Neuroscience Letters, 699, 184-188. Elsevier Ireland Ltd
Neuroscience Letters, 699, 184-188
Neuroscience Letters, 699, pp. 184-188
Heuvel, S A S V D, Doorduin, J, Steegers, M A H, Bronkhorst, E M, Radema, S A, Vissers, K C P, Wal, S E I V D & Alfen, N V 2019, ' Simple surface EMG recording as a noninvasive screening method for the detection of acute oxaliplatin-induced neurotoxicity : a feasibility pilot study ', Neuroscience Letters, vol. 699, pp. 184-188 . https://doi.org/10.1016/j.neulet.2019.02.014
Neuroscience Letters, 699, 184-188
Neuroscience Letters, 699, pp. 184-188
Heuvel, S A S V D, Doorduin, J, Steegers, M A H, Bronkhorst, E M, Radema, S A, Vissers, K C P, Wal, S E I V D & Alfen, N V 2019, ' Simple surface EMG recording as a noninvasive screening method for the detection of acute oxaliplatin-induced neurotoxicity : a feasibility pilot study ', Neuroscience Letters, vol. 699, pp. 184-188 . https://doi.org/10.1016/j.neulet.2019.02.014
Contains fulltext : 203051.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Oxaliplatin-induced neurotoxicity can be a dose-limiting side effect to effective chemotherapy. Acute hyperexcitability causes cold-evoked sensory and motor symptoms, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a404d7b7f36105f535910a7f585643
https://doi.org/10.1016/j.neulet.2019.02.014
https://doi.org/10.1016/j.neulet.2019.02.014
Autor:
Gerrit Jan Veldhuis, Edith B. van Druten, Cathrien S. Tromp-van Driel, Ronald C. Rietbroek, Gerty J. de Klerk, Annebeth W. Haringhuizen, Theo van Voorthuizen, J. E. Vincent, Manuel L. R. Tjin-A-Ton, Anne M. May, Ankie M.T. van der Velden, Geraldine R. Vink, Brigitte C. M. Haberkorn, J. Cornelis B. Hunting, Joyce M. van Dodewaard-de Jong, R. Hoekstra, Lieke H.J. Simkens, Sandra D. Bakker, Patricia Quarles van Ufford-Mannesse, Jeanine M.L. Roodhart, Geert-Jan Creemers, Marjan A. van Dijk, Marco B. Polee, G. Emerens Wensink, Cornelis J. A. Punt, Daan ten Bokkel Huinink, Marloes A. G. Elferink, Bea Tanis, Franchette W P J van den Berkmortel, Henk M.W. Verheul, Danielle Mathijssen-van Stein, Miriam Koopman, Hanneke J. H. M. J. Vestjens, Sandra A Radema, J.F.M. Pruijt, Monique M. Troost, Onno Kranenburg, Jan Willem B. de Groot, Anke J. M. van der Pas, Agnes J. van de Wouw, Emile D. Kerver, Patricia A. H. Hamers, Linda Mol
Publikováno v:
British Journal of Cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
BackgroundMetastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117d001dca85f91775734a7c4208f2d
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
Autor:
Sandra A S van den Heuvel, Kris Vissers, Monique A H Steegers, Luuk R van den Bersselaar, Frank van Haren, Nielka P. van Erp, Sandra A Radema
Publikováno v:
Journal of Oncology Pharmacy Practice, 26(8), 1850-1856
Journal of Oncology Pharmacy Practice, 26, 1850-1856
Journal of Oncology Pharmacy Practice, 26, 8, pp. 1850-1856
van Haren, F, van den Heuvel, S, Radema, S, van Erp, N, van den Bersselaar, L, Vissers, K & Steegers, M 2020, ' Intravenous lidocaine affects oxaliplatin pharmacokinetics in simultaneous infusion ', Journal of Oncology Pharmacy Practice, vol. 26, no. 8, pp. 1850-1856 . https://doi.org/10.1177/1078155220905011
Journal of Oncology Pharmacy Practice, 26, 1850-1856
Journal of Oncology Pharmacy Practice, 26, 8, pp. 1850-1856
van Haren, F, van den Heuvel, S, Radema, S, van Erp, N, van den Bersselaar, L, Vissers, K & Steegers, M 2020, ' Intravenous lidocaine affects oxaliplatin pharmacokinetics in simultaneous infusion ', Journal of Oncology Pharmacy Practice, vol. 26, no. 8, pp. 1850-1856 . https://doi.org/10.1177/1078155220905011
Background Oxaliplatin is a chemotherapeutic agent used to treat malignancies of the gastrointestinal tract. Neuropathy is a frequent dose-limiting side-effect of oxaliplatin therapy, without preventive or curative strategies. Concomitant administrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef07b037a84eab60d165f03f87b98c50
https://research.vumc.nl/en/publications/fc064232-ee45-489e-b765-a1062342eac7
https://research.vumc.nl/en/publications/fc064232-ee45-489e-b765-a1062342eac7
Autor:
Geke Litjens, E. J. M. van Geenen, Lodewijk A.A. Brosens, C.J.H.M. van Laarhoven, Mathias Prokop, Deniece Riviere, Sandra A Radema, John J. Hermans
Publikováno v:
BMC Cancer, 20, 744
BMC Cancer, 20, 1, pp. 744
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer
BMC Cancer, 20, 1, pp. 744
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer
Background At the time of surgery, approximately 10–20% of the patients with pancreatic cancer are considered unresectable because of unexpected liver metastasis, peritoneal carcinomatosis or locally advanced disease. This leads to futile surgical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e66e1d8d99023363215ac12ebcb0ac
https://doi.org/10.1186/s12885-020-07226-0
https://doi.org/10.1186/s12885-020-07226-0